Adenosine Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV) Injection
Available Strengths: 3 mg/mL
Reference Brands: Adenocard(US); Adenocor(EU)
Category:
Critical Care
Adenosine is a rapid-onset IV antiarrhythmic used for PSVT, available in 3 mg/mL strength (6 mg/2 mL, 12 mg/4 mL). Common brands include Adenocard, Adenocor, and Stragen. Widely used in emergency and cardiac care, adenosine is a key product on pharma B2B hospital procurement platforms.
Adenosine is available in Intravenous (IV) Injection
and strengths such as 3 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Adenosine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Adenosine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Adenosine is a fast-acting antiarrhythmic agent used primarily for the acute treatment of paroxysmal supraventricular tachycardia (PSVT). It is administered as a rapid IV bolus and acts by slowing conduction through the AV node. Adenosine is typically available in 3 mg/mL concentration, supplied in 6 mg/2 mL and 12 mg/4 mL vials or pre-filled syringes. US brands include Adenocard and generics by Pfizer and Fresenius. In the EU, Adenocor and Adenosine Stragen are commonly used. As a critical emergency medicine, adenosine is widely procured by hospitals, emergency departments, and ICUs through pharma B2B platforms and institutional tenders.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing